Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma

Pancreatology. 2016 Nov-Dec;16(6):995-1004. doi: 10.1016/j.pan.2016.05.393. Epub 2016 Jun 1.

Abstract

Background/objectives: The vascular heterogeneity of pancreatic ductal adenocarcinoma (PDAC) has never been characterised. We analysed the heterogeneous vascular density of human PDAC along with its prognostic correlation.

Methods: Tissue Microarrays of 87 patients with different pancreatico-biliary pathologies were analysed in an automated manner (Ariol™) after CD31 staining to assess vascular density in juxta-tumoral and panstromal compartments. In vitro and ex vivo assays were carried out to assess the role of PSC.

Results: PDAC has a distinct vascular density and distribution of vessels compared to cholangiocarcinoma. The PDAC juxta-tumoral stroma was hypovascular and the normal adjacent rim was hypervascular compared to the panstromal compartment. These features adversely affected patient prognosis, suggesting a model for spatio-temporal PDAC evolution. Mice aortic rings and 3D organotypic cultures demonstrated pro- and anti-angiogenic signalling from activated PSC and cancer cells respectively. ATRA-induced quiescence suppressed the pro-angiogenic activity of PSC.

Conclusion: Human PDAC has variable vascularity at microscopic level suggesting that novel stromal directed therapies would need to be determined by pathological characteristics.

Keywords: Angiogenesis; Juxta-tumoral; Micro-environment; Pancreatic stellate cells; Panstromal.

MeSH terms

  • Adenocarcinoma / pathology*
  • Animals
  • Blood Vessels / pathology*
  • Carcinoma, Pancreatic Ductal / pathology*
  • Cells, Cultured
  • Cholangiocarcinoma / pathology
  • Humans
  • Mice
  • Microarray Analysis
  • Microcirculation / drug effects
  • Neovascularization, Pathologic / pathology
  • Organ Culture Techniques
  • Pancreatic Stellate Cells / pathology*
  • Prognosis
  • Survival Analysis
  • Tretinoin / therapeutic use
  • Tumor Microenvironment

Substances

  • Tretinoin